APA (7th ed.) Citation

Yingqiao Ding, Yuan Fan, Xingchen Li, Yiqin Wang, Jianliu Wang, & Li Tian. (2022). Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients. BMC.

Chicago Style (17th ed.) Citation

Yingqiao Ding, Yuan Fan, Xingchen Li, Yiqin Wang, Jianliu Wang, and Li Tian. Metabolic Syndrome Is an Independent Risk Factor for Time to Complete Remission of Fertility-sparing Treatment in Atypical Endometrial Hyperplasia and Early Endometrial Carcinoma Patients. BMC, 2022.

MLA (9th ed.) Citation

Yingqiao Ding, et al. Metabolic Syndrome Is an Independent Risk Factor for Time to Complete Remission of Fertility-sparing Treatment in Atypical Endometrial Hyperplasia and Early Endometrial Carcinoma Patients. BMC, 2022.